Nektar Therapeutics (NKTR)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.8000 |
| Open | 1.8100 |
| Bid | 1.7100 x 300 |
| Ask | 1.7700 x 600 |
| Day's range | 1.7150 - 1.8100 |
| 52-week range | 0.4100 - 1.9300 |
| Volume | |
| Avg. volume | 2,588,145 |
| Market cap | 322.262M |
| Beta (5Y monthly) | 0.71 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.4500 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.60 |
Insider MonkeyNektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript
Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript May 9, 2024 Nektar Therapeutics isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. Welcome to the Nektar Therapeutics First Quarter 2024 Financial Results Conference […]
- GuruFocus.com
Nektar Therapeutics (NKTR) First Quarter 2024 Earnings Overview
Aligns with EPS Projections Amidst Financial and Operational Developments
ZacksNektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
Nektar (NKTR) reports a narrower-than-expected loss in the first quarter of 2024 and tops revenue estimates.
© 2024 Yahoo. All rights reserved.